Login
Home
Charts
Search
Watchlist
Products

Aarti Pharmalabs Ltd

AARTIPHARM·NSE
₹940.10+6.38%Wed, 23 Sept '26 15:57
Industry:Pharma - API
Indices:

Aarti Pharmalabs Ltd

AARTIPHARM
NSE
₹940.10
+6.38%
|Wed, 23 Sept '26 15:57
SOICxStockScans Reports
Industry
Pharma - API
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹8,497Cr
Close
Close Price
₹937.00
Industry
Industry
Pharma - API
PE
Price To Earnings
39.86
PS
Price To Sales
4.32
Revenue
Revenue
₹1,969Cr
Rev Gr TTM
Revenue Growth TTM
1.20%
PAT Gr TTM
PAT Growth TTM
-20.01%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
440449506555458538564386418432583536
Growth YoY
Revenue Growth YoY%
-17.2-4.94.321.24.219.911.5-30.5-8.7-19.63.438.7
Expenses
ExpensesCr
352353388459364409418291344330470400
Operating Profit
Operating ProfitCr
889611896941291469575102113136
OPM
OPM%
20.021.323.217.420.423.925.824.717.923.719.425.4
Other Income
Other IncomeCr
112245-20-12148
Interest Expense
Interest ExpenseCr
44556107711131713
Depreciation
DepreciationCr
181919202123232325292830
PBT
PBTCr
677496747210111565396382101
Tax
TaxCr
152131181727261611152125
PAT
PATCr
525365555574885028486176
Growth YoY
PAT Growth YoY%
1.410.752.217.85.440.235.4-10.7-48.9-35.2-30.853.8
NPM
NPM%
11.811.812.910.011.913.815.712.86.711.110.514.2
EPS
EPS₹
5.75.87.26.16.08.29.85.53.15.36.78.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
440449506555458538564386418432583536
Growth YoY
Revenue Growth YoY%
-17.2-4.94.321.24.219.911.5-30.5-8.7-19.63.438.7
Expenses
ExpensesCr
352353388459364409418291344330470400
Operating Profit
Operating ProfitCr
889611896941291469575102113136
OPM
OPM%
20.021.323.217.420.423.925.824.717.923.719.425.4
Other Income
Other IncomeCr
112245-20-12148
Interest Expense
Interest ExpenseCr
44556107711131713
Depreciation
DepreciationCr
181919202123232325292830
PBT
PBTCr
677496747210111565396382101
Tax
TaxCr
152131181727261611152125
PAT
PATCr
525365555574885028486176
Growth YoY
PAT Growth YoY%
1.410.752.217.85.440.235.4-10.7-48.9-35.2-30.853.8
NPM
NPM%
11.811.812.910.011.913.815.712.86.711.110.514.2
EPS
EPS₹
5.75.87.26.16.08.29.85.53.15.36.78.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
01,2001,9451,8532,1151,8191,969
Growth
Revenue Growth%
62.1-4.814.2-14.01.2
Expenses
ExpensesCr
09931,6031,4671,6511,4501,543
Operating Profit
Operating ProfitCr
0207342386464369426
OPM
OPM%
17.317.620.822.020.321.6
Other Income
Other IncomeCr
0325101523
Interest Expense
Interest ExpenseCr
0122117274753
Depreciation
DepreciationCr
042637387104112
PBT
PBTCr
0155261300361233284
Tax
TaxCr
0336784885871
PAT
PATCr
0122193217272175213
Growth
PAT Growth%
26,57,765.258.312.125.6-35.9-20.0
NPM
NPM%
10.29.911.712.99.610.8
EPS
EPS₹
-0.213.521.423.930.119.323.5
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
01,2001,9451,8532,1151,8191,969
Growth
Revenue Growth%
62.1-4.814.2-14.01.2
Expenses
ExpensesCr
09931,6031,4671,6511,4501,543
Operating Profit
Operating ProfitCr
0207342386464369426
OPM
OPM%
17.317.620.822.020.321.6
Other Income
Other IncomeCr
0325101523
Interest Expense
Interest ExpenseCr
0122117274753
Depreciation
DepreciationCr
042637387104112
PBT
PBTCr
0155261300361233284
Tax
TaxCr
0336784885871
PAT
PATCr
0122193217272175213
Growth
PAT Growth%
26,57,765.258.312.125.6-35.9-20.0
NPM
NPM%
10.29.911.712.99.610.8
EPS
EPS₹
-0.213.521.423.930.119.323.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0045454545
Reserves
ReservesCr
01,3411,5131,7121,9452,079
Current Liabilities
Current LiabilitiesCr
0581601694657938
Non Current Liabilities
Non Current LiabilitiesCr
07385131259420
Total Liabilities
Total LiabilitiesCr
02,0402,2442,5822,9063,482
Current Assets
Current AssetsCr
01,0281,1631,3461,3221,397
Non Current Assets
Non Current AssetsCr
01,0121,0811,2361,5842,084
Total Assets
Total AssetsCr
02,0402,2442,5822,9063,482
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0045454545
Reserves
ReservesCr
01,3411,5131,7121,9452,079
Current Liabilities
Current LiabilitiesCr
0581601694657938
Non Current Liabilities
Non Current LiabilitiesCr
07385131259420
Total Liabilities
Total LiabilitiesCr
02,0402,2442,5822,9063,482
Current Assets
Current AssetsCr
01,0281,1631,3461,3221,397
Non Current Assets
Non Current AssetsCr
01,0121,0811,2361,5842,084
Total Assets
Total AssetsCr
02,0402,2442,5822,9063,482

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-44250216330262
Investing Cash Flow
Investing Cash FlowCr
0-139-158-215-412-431
Financing Cash Flow
Financing Cash FlowCr
0260-1631065171
Net Cash Flow
Net Cash FlowCr
078-7112-172
Free Cash Flow
Free Cash FlowCr
0-18514861-72-147
CFO To PAT
CFO To PAT%
0.0-35.8129.399.8121.2149.9
CFO To EBITDA
CFO To EBITDA%
0.0-21.173.156.071.170.9
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-44250216330262
Investing Cash Flow
Investing Cash FlowCr
0-139-158-215-412-431
Financing Cash Flow
Financing Cash FlowCr
0260-1631065171
Net Cash Flow
Net Cash FlowCr
078-7112-172
Free Cash Flow
Free Cash FlowCr
0-18514861-72-147
CFO To PAT
CFO To PAT%
0.0-35.8129.399.8121.2149.9
CFO To EBITDA
CFO To EBITDA%
0.0-21.173.156.071.170.9

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,4893,9426,7845,3428,497
Price To Earnings
Price To Earnings
12.918.224.930.639.9
Price To Sales
Price To Sales
1.32.13.22.94.3
Price To Book
Price To Book
1.62.23.42.54.0
EV To EBITDA
EV To EBITDA
7.910.915.516.319.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.731.234.136.8
OPM
OPM%
17.317.620.822.020.321.6
NPM
NPM%
10.29.911.712.99.610.8
ROCE
ROCE%
-1.910.015.915.616.110.010.0
ROE
ROE%
-2.09.112.412.313.78.28.2
ROA
ROA%
-1.86.08.68.49.45.05.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,4893,9426,7845,3428,497
Price To Earnings
Price To Earnings
12.918.224.930.639.9
Price To Sales
Price To Sales
1.32.13.22.94.3
Price To Book
Price To Book
1.62.23.42.54.0
EV To EBITDA
EV To EBITDA
7.910.915.516.319.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.731.234.136.8
OPM
OPM%
17.317.620.822.020.321.6
NPM
NPM%
10.29.911.712.99.610.8
ROCE
ROCE%
-1.910.015.915.616.110.010.0
ROE
ROE%
-2.09.112.412.313.78.28.2
ROA
ROA%
-1.86.08.68.49.45.05.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Aarti Pharmalabs Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/3zngl4y9pqkbiyfzmi9z4vwj.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/ylqw2ywgx0nz08bokqdrpozz.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/e2ott5owgrcaxuk4ns9eqaey.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/io9i6dzga58nvs15opqkm9eb.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/gkbj1867yiusifdkvu4qesne.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/oyutd8mwtdwl8y7zp9smb9u5.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/7tjyum1xzf839laoofo0c4oj.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/2fh91d1pu39s2hx76jyobrhi.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/tcwevb3z4f83risg7cjsr88n.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/8y3hl7lmsqjii28j4snsq00j.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/0e15ngmx1r2or832aiu8qdac.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/bzd5lyuyzqmdvrnni1s6zzu3.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/1nkl5jbdbw4utpsw3tc0s6qd.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ksbcd16vxml1hdxzakq1t19k.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/27hbrb3pvzsyniaqdea9thse.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/8tx05vsk9f9jqyqmzii5zu5a.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/7iuewgmtr0k8to5755tgxedn.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/qfwnbum9w5i7qrtfoz7zaio5.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/jirnl6l8pb0y3525d57rt1qo.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/dpmc4zaygxjktut8l1l7cpqw.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/03q7v7748nba6b4339thnmbp.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/mdev7jjozng9z68c0z5o4ww0.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/plxoyn6w6okkp1jkbrh9dzyh.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/b6gep6l4nsty9g8otia6eyx8.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/luzbx5kr64y8haq7llyjvxnn.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/ruv1jar66ma9cf3wkg1moixw.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/xw2cw9ewfy2a7hskwo03cgcv.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/nuujvmi6hhipe10hsfctdhge.pdf

Concall Transcript Summaries — Aarti Pharmalabs Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202606/3zngl4y9pqkbiyfzmi9z4vwj.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202603/ylqw2ywgx0nz08bokqdrpozz.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202512/e2ott5owgrcaxuk4ns9eqaey.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202509/io9i6dzga58nvs15opqkm9eb.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202506/gkbj1867yiusifdkvu4qesne.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202503/oyutd8mwtdwl8y7zp9smb9u5.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202412/7tjyum1xzf839laoofo0c4oj.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AAARTIPHARM/transcript-notes/202409/2fh91d1pu39s2hx76jyobrhi.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies